GlassScriptPhysician profile
John A Sunyecz
NPI 1316982416
$20,868.83
in general payments reported to CMS, 2019-2025
28 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $111 · 2021: $141 · 2022: $3,111 · 2023: $3,549 · 2024: $784 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,767 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,650 · Food and Beverage: $961 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,766.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,650.00 |
| Food and Beverage | $961.07 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $13,703.13 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $4,425.84 | 2019 | |
| Coloplast Corp | $838.76 | 2022-2024 | Restorelle, Altis, Saffron |
| Medical Device Business Services, INC. | $507.20 | 2024 | |
| Coopersurgical, INC. | $223.87 | 2019-2021 | |
| Abbvie INC. | $193.44 | 2019-2023 | Orilissa |
| Boston Scientific Corporation | $95.51 | 2019-2025 | Axonics, Solyx Sis System |
| Organon LLC | $86.58 | 2021-2024 | Nexplanon |
| Astellas Pharma US INC | $83.61 | 2023-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $83.21 | 2023-2025 | |
| Dilon Technologies, INC. | $81.29 | 2023-2024 | Hemoblast Bellows |
| Exact Sciences Corporation | $73.13 | 2025 | The Cologuard Plus Collection Kit |
| Amgen INC. | $67.45 | 2022-2024 | Evenity, Prolia |
| Pfizer INC. | $60.52 | 2021-2023 | |
| Axonics, INC. | $48.11 | 2023-2024 | Axonics |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $36.43 | 2023 | Arista Ah Flexitip |
| Exeltis, USA INC. | $33.15 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $30.01 | 2023 | Myfembree, Gemtesa |
| Covidien LP | $29.96 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $27.56 | 2023 | Caldolor |
| Mylan Pharmaceuticals INC. | $24.02 | 2022 | |
| Ethicon US, LLC | $19.37 | 2024 | Harmonic |
| Radius Health, INC. | $18.61 | 2019 | |
| Therapeuticsmd, INC. | $18.30 | 2022 | |
| Novo Nordisk INC | $16.37 | 2023 | Wegovy |
| Hologic Sales and Service, LLC | $15.47 | 2022 | |
| Urovant Sciences INC | $14.58 | 2022 | |
| Myovant Sciences INC. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sunyecz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.